Results 121 to 130 of about 664,100 (294)
Engineered neutrophil‐derived vesicles (SOD2‐Fer‐1@CVs) co‐delivering antioxidant and ferroptosis‐inhibitory agents enable inflammation‐targeted, ROS‐responsive therapy for ischemia–reperfusion injury in lung transplantation. Synergizing with ex vivo lung perfusion, this strategy alleviates oxidative stress and inflammation, restores vascular integrity,
Hao‐Xiang Yuan +10 more
wiley +1 more source
PB2662: ABO BLOOD GROUP TYPE AND RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH LYMPHOMA
Vladimir Otasevic +5 more
doaj +1 more source
Lymphomatosis in Chicks Immunized Against a Transplantable Lymphoma
George R. Sharpless, Robert Love
openalex +1 more source
Failure of syngeneic bone marrow cells to protect against MC-induced lymphoma in dba/2 mice [PDF]
Louise Chen, I. Berenblum
openalex +1 more source
This study identified that STK33 may serve as a target of Bufalin, which induces the degradation of STK33 and inhibits the growth of TNBC. Furthermore, STK33 is highly expressed in TNBC and enhances TNBC cell proliferation by phosphorylating and stabilizing CCAR1.
Shilong Jiang +11 more
wiley +1 more source
Mitochondrial transplantation induces macrophage polarization toward an anti‐inflammatory M2 phenotype, enhances their reparative capacities, and facilitates mitochondrial transfer to cardiomyocytes, collectively promoting tissue repair and functional recovery post‐myocardial infarction.
Yuning Zhang +10 more
wiley +1 more source
The Development of Hodgkin’s Disease and Lymphoma during Anticonvulsant Therapy [PDF]
George A. Hyman, Sheldon C. Sommers
openalex +1 more source
The Authors report a case of Burkitt's lymphoma of the stomach in a patient treated ten years before for Hodgkin's lymphoma. Gastrectomy associated to chemotherapy is more effective than surgical treatment alone and avoids the risk of gastric perforation during medical treatment.
SANTORO G, ROCCO, PASQUALE
openaire +2 more sources
An integrative analysis combining in vitro genome‐wide immune screens, in vivo ICB screens, and clinical data mining identifies METTL5 as a key tumor‐intrinsic immune factor. Mechanistic studies further reveal the importance of the METTL5‐ATF4‐SLC7A11/SLC3A2‐ferroptosis axis in modulating antitumor immune responses. These findings highlight METTL5 as a
Jiakai Hou +30 more
wiley +1 more source

